medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.medvis-339Research ArticleПОВЕРХНОСТНЫЕ ОРГАНЫSUPERFICIAL ORGANSКальцинаты молочной железы: дифференциальная диагностика и прогностическое значениеBreast Calcifications: Etiology, Classification, PrognosisОксанчукЕ. А.OksanchukE. A.

младший научный сотрудник лаборатории рентгенорадиологических, ультразвуковых и рентгенохирургических технологий в маммологии (Маммологический центр) научно-исследовательского отдела раннего канцерогенеза, профилактики, диагностики и комплексного лечения онкологических заболеваний женских репродуктивных органов,

141011 Московская область, г. Мытищи, ул. Колпакова, д. 34Б, кв. 25

junior researcher of laboratory of X-ray radiology, ultrasound and X-ray surgical techniques in mammalogy (the Federal Breast Center) research department of early carcinogenesis, prevention, diagnosis and comprehensive treatment of cancers of the female reproductive organs,

141011 Moscow region, Kolpakova str., 34b-25

Loksanchuk@gmail.comМескихЕ. В.MeskihE. V.

доктор мед. наук, профессор, заведующая лабораторией рентгенорадиологических, ультразвуковых и рентгенохирургических технологий в маммологии (Маммологический центр) научно-исследовательского отдела раннего канцерогенеза, профилактики, диагностики и комплексного лечения онкологических заболеваний женских репродуктивных органов,

Москва

doct. of med. sci., professor, head of laboratory of X-ray radiology, ultrasound and X-ray surgical techniques in mammalogy (the Federal Breast Center) research department of early carcinogenesis, prevention, diagnosis and comprehensive treatment of cancers of the female reproductive organs,

Moscow

КолесникА. Ю.KolesnikA. U.

канд. мед. наук, научный сотрудник лаборатории рентгенорадиологических, ультразвуковых и рентгенохирургических технологий в маммологии (Маммологический центр) научно-исследовательского отдела раннего канцерогенеза, профилактики, диагностики и комплексного лечения онкологических заболеваний женских репродуктивных органов,

Москва

cand. of med. sci., researcher of laboratory of X-ray radiology, ultrasound and X-ray surgical techniques in mammalogy (the Federal Breast Center) research department of early carcinogenesis, prevention, diagnosis and comprehensive treatment of cancers of the female reproductive organs,

Moscow

НудновН. В.NudnovN. V.

доктор мед. наук, профессор, заместитель директора по научной работе,

Москва

dokt. of med. sci., professor, Deputy Director for Scientific Research,

Moscow

ФГБУ “Российский научный центр рентгенорадиологии” Минздрава РоссииРоссияRussian Scientific Center of RoentgenoradiologyRussian Federation20162810201605120127Copyright © Оксанчук Е.А., Меских Е.В., Колесник А.Ю., Нуднов Н.В., 20162016Оксанчук Е.А., Меских Е.В., Колесник А.Ю., Нуднов Н.В.Oksanchuk E.A., Meskih E.V., Kolesnik A.U., Nudnov N.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.vidar.ru/jour/article/view/339Цель исследования

Цель исследования: провести анализ мировой литературы для оценки характеристики микрокальцинатов, их этиологии, классификации, клинического и прогностического значения и сравнить полученные данные с результатами исследований, проведенных в Российском научном центре рентгенорадиологии (РНЦРР).

Материал и методы

Материал и методы. На основании анализа данных литературы проанализированы 1195 маммограмм, выполненных женщинам в возрасте от 32 до 78 лет в Маммологическом центре РНЦРР за январь–февраль 2015 г. Исследования проводили на аппаратах маммографической системы Amulet фирмы Fujifilm. Всем пациенткам выполняли снимки в прямой и косой проекциях. Полученные данные сравнивали с результатами опубликованных исследований.

Результаты

Результаты. Микрокальцинаты в молочных железах широко распространены и являются признаками как злокачественных, так и доброкачественных образований. При этом микрокальцинаты встречаются при злокачественных процессах в 40% случаев и в половине случаев образования непальпируемые. Кроме того, наличие кальцинатов в опухоли свидетельствует об ухудшении прогноза.

Выводы

Выводы. Микрокальцинаты являются важным диагностическим критерием, требующим более глубоко изучения и совершенствования методов их диагностики. 

Objective

Objective. To analyze of numerous works devoted to the evaluation of microcalcifications, their classification into benign and malignant, as well as the prognosis of malignant diseases in the presence of calcifications in them.

Materials and methods

Materials and methods. Was analyzed works devoted to the evaluation of microcalcifications, as well as was evaluated 1195 mammograms, which was performed on the AMULET digital mammography system by FUJIFILM in our center in January–February of 2015. These data was compared.

Results

Results. Breast microcalcifications are widespread criteria both benign and malignant lesions of the breast. It occurs in about 40% of breast cancers, and a half of them are not palpable. Besides, breast cancer with microcalcifications have worse prognosis.

Conclusion

Conclusion. Microcalcifications are one of the most important marker of breast cancer. It needs to be studied more carefully. 

микрокальцинатырак молочной железыгиперплазии молочных железфиброаденомамастэктомиярезекция молочной железыmicrocalcificationsbreast cancerhyperplasias of the breastfibroadenomamastectomybreast resectionReferencesYunus M., Ahmed N., Masroor I. et al. Mammographic criteria for determining the diagnostic value of microcalcifications in the detection of early breast cancer. J. Pak. Med. Assoc. 2004; 54: 24–29.Yunus M., Ahmed N., Masroor I. et al. Mammographic criteria for determining the diagnostic value of microcalcifications in the detection of early breast cancer. J. Pak. Med. Assoc. 2004; 54: 24–29.Morgan M.P., Cooke M.M., McCarthy G.M. Microcalcifications associated with breast cancer: an epiphenome non or biologically significant feature of selected tumors? J. of mammary gland biology and neoplasia. 2005; 10 (2): 181–187.Morgan M.P., Cooke M.M., McCarthy G.M. Microcalcifications associated with breast cancer: an epiphenome non or biologically significant feature of selected tumors? J. of mammary gland biology and neoplasia. 2005; 10 (2): 181–187.Ayvaci M., Alagoz O., Chhatwal J. et al. Predicting invasive breast cancer versus DCIS in different age groups. BMC Cancer. 2014; 14: 584–594.Ayvaci M., Alagoz O., Chhatwal J. et al. Predicting invasive breast cancer versus DCIS in different age groups. BMC Cancer. 2014; 14: 584–594.Gajdos C., Tartter P.I., Bleiweiss I. J. et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann. Surg. 2002; 235 (2): 246–251.Gajdos C., Tartter P.I., Bleiweiss I. J. et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann. Surg. 2002; 235 (2): 246–251.Naseem M., Murray J., Hilton J.F. et al. Mammographic microcalcifications and breast cancer tumorigenesis: a radiologic-pathologic analysis. BMC Cancer. 2015; 15: 2–9.Naseem M., Murray J., Hilton J.F. et al. Mammographic microcalcifications and breast cancer tumorigenesis: a radiologic-pathologic analysis. BMC Cancer. 2015; 15: 2–9.Evans A., Pinder S., Ellis I. et al. Breast Calcification. By MPG Books Ltd, Bodmin, Cornwall, 2002. 172 p.Evans A., Pinder S., Ellis I. et al. Breast Calcification. By MPG Books Ltd, Bodmin, Cornwall, 2002. 172 p.Корженкова Г.П., Долгушин Б.И. Опыт использования цифровой маммографии. Радиология–практика. 2009; 6: 42–48. Korzhenkova G., Dolgushin B. Experience of digital mammography using. Radiologia-praktica. 2009; 6: 42–48. (In Russian)Корженкова Г.П., Долгушин Б.И. Опыт использования цифровой маммографии. Радиология–практика. 2009; 6: 42–48. Korzhenkova G., Dolgushin B. Experience of digital mammography using. Radiologia-praktica. 2009; 6: 42–48. (In Russian)Sickles E.A. Breast calcifications: mammographic evaluation. Radiology. 1986; 160: 289–293.Sickles E.A. Breast calcifications: mammographic evaluation. Radiology. 1986; 160: 289–293.Fiaschetti V., Pistolese Ch.A., Perretta T. et al. BI-RADs microcalcifications: correlation between MRI and histological findings. ISRN Oncology. 2011; 10; 1–7.Fiaschetti V., Pistolese Ch.A., Perretta T. et al. BI-RADs microcalcifications: correlation between MRI and histological findings. ISRN Oncology. 2011; 10; 1–7.Кабин Ю.В., Громов А.И., Капустин В.В.. Применение ультразвуковой технологии улучшения визуализации микрокальцинатов (MicroPure) в диагностике рака молочной железы. Радиология–практика. 2011; 6: 47–53. Kabin Yu.V., Gromov A.I., Kapustin V.V. Application of ultrasound technology of calcifications visualization improvement (MicroPure) for breast cancer diagnostics. Radiologia-praktica. 2011; 6: 47–53. (In Russian)Кабин Ю.В., Громов А.И., Капустин В.В.. Применение ультразвуковой технологии улучшения визуализации микрокальцинатов (MicroPure) в диагностике рака молочной железы. Радиология–практика. 2011; 6: 47–53. Kabin Yu.V., Gromov A.I., Kapustin V.V. Application of ultrasound technology of calcifications visualization improvement (MicroPure) for breast cancer diagnostics. Radiologia-praktica. 2011; 6: 47–53. (In Russian)Lee Spangler M., Zuley M.L., Sumkin J.H. et al. Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison. Am. J. Roentgenol. 2011; 196: 320–324.Lee Spangler M., Zuley M.L., Sumkin J.H. et al. Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison. Am. J. Roentgenol. 2011; 196: 320–324.Рожкова Н.И., Бурдина И.И., Запирова С.Б. и др. Контрастная двуэнергетическая спектральная маммография (обзор). Исследования и практика в медицине. 2015; 2 (4): 82–87. Rozhkova N.I., Burdina I.I., Zapirova S.B. et al. Contrast enhanced spectral mammography (CESM) (review). Research'n Practical Medicine Journal. 2015; 2 (4): 82–87. (In Russian)Рожкова Н.И., Бурдина И.И., Запирова С.Б. и др. Контрастная двуэнергетическая спектральная маммография (обзор). Исследования и практика в медицине. 2015; 2 (4): 82–87. Rozhkova N.I., Burdina I.I., Zapirova S.B. et al. Contrast enhanced spectral mammography (CESM) (review). Research'n Practical Medicine Journal. 2015; 2 (4): 82–87. (In Russian)Scimeca M., Giannini E., Antonacci C. et al. Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics. BMC Cancer. 2014; 14: 286–296.Scimeca M., Giannini E., Antonacci C. et al. Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics. BMC Cancer. 2014; 14: 286–296.Daniaux M., De Zordo T., Santner W. et al. Dual-energy contrast-enhanced spectral mammography (CESM). Arch. Gynecol. Obstet. 2015; 292: 739–747.Daniaux M., De Zordo T., Santner W. et al. Dual-energy contrast-enhanced spectral mammography (CESM). Arch. Gynecol. Obstet. 2015; 292: 739–747.Tse G.M., Tan P.H., Cheung H.S. et al. Intermediate to highly suspicious calcification in breast lesions: a radiopathologic correlation. Breast Cancer Res. Treat. 2008; 110: 1–7.Tse G.M., Tan P.H., Cheung H.S. et al. Intermediate to highly suspicious calcification in breast lesions: a radiopathologic correlation. Breast Cancer Res. Treat. 2008; 110: 1–7.Sornrner G., Kopsa H., Zazgornik J. et al. Breast calcifications in renal hyperparathyroidis. Am. J. Roentgenol. 1987; 148: 855–857.Sornrner G., Kopsa H., Zazgornik J. et al. Breast calcifications in renal hyperparathyroidis. Am. J. Roentgenol. 1987; 148: 855–857.Baldi C., Vazquez G., Boland R. Capacitative calcium influx in human epithelial breast cancer and nontumorigenic cells occurs through Ca2+ entry pathways with different permeabilities to divalent cations. J. Cell. Biochem. 2003; 88: 1265–1272.Baldi C., Vazquez G., Boland R. Capacitative calcium influx in human epithelial breast cancer and nontumorigenic cells occurs through Ca2+ entry pathways with different permeabilities to divalent cations. J. Cell. Biochem. 2003; 88: 1265–1272.Zhang L., Liu Y., Song F. et al. Functional SNP in the microRNA-367 binding site in the 3 UTR of the calcium channel ryanodine receptor gene 3(RYR3) affects breast cancer risk and calcification. PNAS. 2011; 108 (33): 13653–13658.Zhang L., Liu Y., Song F. et al. Functional SNP in the microRNA-367 binding site in the 3 UTR of the calcium channel ryanodine receptor gene 3(RYR3) affects breast cancer risk and calcification. PNAS. 2011; 108 (33): 13653–13658.Uematsu T., Kasami M., Yuen S. Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications. Breast Cancer. 2008; 15 (4): 291–297.Uematsu T., Kasami M., Yuen S. Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications. Breast Cancer. 2008; 15 (4): 291–297.Demetri-Lewis A., Slanetz P.J., Eisenberg R.L. Breast calcifications: the focal group. Am. J. Roentgenol. 2012; 198: 325–343.Demetri-Lewis A., Slanetz P.J., Eisenberg R.L. Breast calcifications: the focal group. Am. J. Roentgenol. 2012; 198: 325–343.Baker R., Rogers K.D., Shepherd N. et al. New relationships between breast microcalcifications and cancer. Br. J. Cancer. 2010; 103 (7): 1034–1039.Baker R., Rogers K.D., Shepherd N. et al. New relationships between breast microcalcifications and cancer. Br. J. Cancer. 2010; 103 (7): 1034–1039.Scimeca M., Antonacci C., Bonanno E. et al. Breast microcalcifications: a focus. J. Cell. Sci. Ther. 2015; S8; 2–9.Scimeca M., Antonacci C., Bonanno E. et al. Breast microcalcifications: a focus. J. Cell. Sci. Ther. 2015; S8; 2–9.Berg W.A., Arnoldus C.L., Teferra E. et al. Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy. Radiology. 2001; 221: 495–503.Berg W.A., Arnoldus C.L., Teferra E. et al. Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy. Radiology. 2001; 221: 495–503.Muhimmah I., Oliver A., Denton E.R.E. et al. Comparison between Wolfe, Boyd, BI-RADS and Tabar Based Mammographic Risk Assessment. IWDM. 2006; 4046: 407–415.Muhimmah I., Oliver A., Denton E.R.E. et al. Comparison between Wolfe, Boyd, BI-RADS and Tabar Based Mammographic Risk Assessment. IWDM. 2006; 4046: 407–415.Burnside E.S, Ochsner J.E., Fowler K.J, Fine J.P. et al. Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology. 2007; 242: 388–395.Burnside E.S, Ochsner J.E., Fowler K.J, Fine J.P. et al. Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology. 2007; 242: 388–395.Balleyguier C., Ayadi S., Nguyen K.V. et al. BIRADS classification in mammography. Eur. J. Radiol. 2007; 61: 192–194.Balleyguier C., Ayadi S., Nguyen K.V. et al. BIRADS classification in mammography. Eur. J. Radiol. 2007; 61: 192–194.D’Orsi C.J., Sickles E.A., Mendelson E.B. et al. ACR BIRADS® Atlas, Breast Imaging Reporting and Data System. By Reston V.A. Am. Coll. Radiol. 2013; 125–143.D’Orsi C.J., Sickles E.A., Mendelson E.B. et al. ACR BIRADS® Atlas, Breast Imaging Reporting and Data System. By Reston V.A. Am. Coll. Radiol. 2013; 125–143.

The authors declare that there are no conflicts of interest present.